News & Events

News & Events

Latest

Hands of CDC scientist as they prepare to test a patient’s sample for SARS-CoV-2
Hands of CDC scientist as they prepare to test a patient’s sample for SARS-CoV-2
Placebo-Controlled Trials of Covid-19 Vaccines — Why We Still Need Them
New England Journal of Medicine,

Biostatistics faculty members Tom Fleming and Betz Halloran sit on the WHO Ad Hoc Expert Group on the Next Steps for COVID-19 Vaccine Evaluation. In a recent New England Journal of Medicine article, the group notes that even though the efficacy of some COVID-19 vaccines appears to be high, reliable information will still be needed on longer-term safety and duration of protection.

Jim Hughes
Jim Hughes
New HIV prevention treatment proves 89% more effective than current standard of care
Lead biostatistician Jim Hughes discusses study results and design challenges.
Witten and Gilbert
Witten and Gilbert
UW Biostatistics faculty among 2020 highly cited researchers
Two core faculty members from the University of Washington Department of Biostatistics in the School of Public Health have been recognized as
Word Aducanumab superimposed over graphic of human brain
Word Aducanumab superimposed over graphic of human brain
No Love for Aducanumab From FDA Advisers — Panel rejects mixed findings for controversial Alzheimer's drug
Medpage Today,

"This analysis seems to be subject to the Texas sharpshooter fallacy," where someone first fires a shot at a barn then paints a target around the bullet hole, said panelist and biostatistician Scott Emerson, MD, PhD, of the University of Washington in Seattle.

Headshot of Jon Wakefiled
Headshot of Jon Wakefiled
Design- and Model-Based Approaches to Small-Area Estimation in A Low- and Middle-Income Country Context: Comparisons and Recommendations
Journal of Survey Statistics and Methodology,

Professor of Biostatistics Jon Wakefield is co-author of a recent paper that notes the explosion in geographic studies in low- and middle-income countries and investigates the extent to which accounting for the sample design affects the predictive performance at the aggregate level of interest for health policy decisions.